Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.06)
# 483
Out of 5,182 analysts
352
Total ratings
42.66%
Success rate
15.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $27.06 | +84.77% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $2.74 | +337.96% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $302.11 | +88.67% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $8.44 | +373.93% | 17 | Aug 4, 2025 | |
| ATAI AtaiBeckley | Maintains: Buy | $10 → $15 | $4.33 | +246.42% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $24.47 | -59.13% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.38 | +262.32% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.20 | +4,875.12% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $7.70 | +874.03% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $28.79 | +247.34% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $18.05 | +287.81% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.90 | +455.31% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $7.12 | +743.29% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $70.13 | +14.07% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $19.85 | +101.51% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.77 | +695.76% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $31.16 | +124.65% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $30.56 | +161.78% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.85 | +440.54% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.34 | +2,799.39% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $10.28 | +970.04% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $88.99 | -4.48% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $12.17 | +458.75% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $67.25 | +405.58% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $27.06
Upside: +84.77%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $2.74
Upside: +337.96%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $302.11
Upside: +88.67%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $8.44
Upside: +373.93%
AtaiBeckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.33
Upside: +246.42%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $24.47
Upside: -59.13%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.38
Upside: +262.32%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.20
Upside: +4,875.12%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $7.70
Upside: +874.03%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $28.79
Upside: +247.34%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $18.05
Upside: +287.81%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.90
Upside: +455.31%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $7.12
Upside: +743.29%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $70.13
Upside: +14.07%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $19.85
Upside: +101.51%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $3.77
Upside: +695.76%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $31.16
Upside: +124.65%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $30.56
Upside: +161.78%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.85
Upside: +440.54%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.34
Upside: +2,799.39%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $10.28
Upside: +970.04%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $88.99
Upside: -4.48%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $12.17
Upside: +458.75%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $67.25
Upside: +405.58%